BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1164 related articles for article (PubMed ID: 28551099)

  • 1. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
    Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
    Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation.
    Liu Y; Hu J; Wu J; Zhu C; Hui Y; Han Y; Huang Z; Ellsworth K; Fan W
    J Neuroinflammation; 2012 May; 9():98. PubMed ID: 22624500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson's Disease is Mediated by α7-Nicotinic Receptors.
    El Nebrisi E; Javed H; Ojha SK; Oz M; Shehab S
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of α7 nicotinic acetylcholine receptors protects astrocytes against oxidative stress-induced apoptosis: implications for Parkinson's disease.
    Liu Y; Zeng X; Hui Y; Zhu C; Wu J; Taylor DH; Ji J; Fan W; Huang Z; Hu J
    Neuropharmacology; 2015 Apr; 91():87-96. PubMed ID: 25486621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of α7-nAChRs protects SH-SY5Y cells from 1-methyl-4-phenylpyridinium-induced apoptotic cell death via ERK/p53 signaling pathway.
    Xu S; Yang B; Tao T; Zhang J; Liu Y; Hu J; Fan Y; Zhang G
    J Cell Physiol; 2019 Aug; 234(10):18480-18491. PubMed ID: 30912145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of non-alpha7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture.
    Jeyarasasingam G; Tompkins L; Quik M
    Neuroscience; 2002; 109(2):275-85. PubMed ID: 11801364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
    Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
    Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease.
    Zhou T; Zu G; Zhang X; Wang X; Li S; Gong X; Liang Z; Zhao J
    Neuropharmacology; 2016 Feb; 101():480-9. PubMed ID: 26525190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease.
    Zhang L; Huang L; Chen L; Hao D; Chen J
    Toxicol Lett; 2013 Oct; 222(2):155-63. PubMed ID: 23911879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
    Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
    Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease.
    Lin JG; Chen CJ; Yang HB; Chen YH; Hung SY
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for neuroprotection and repair.
    L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Deleidi M; Serapide MF; Pluchino S; Marchetti B
    J Neurosci; 2012 Feb; 32(6):2062-85. PubMed ID: 22323720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.
    Ghosh A; Saminathan H; Kanthasamy A; Anantharam V; Jin H; Sondarva G; Harischandra DS; Qian Z; Rana A; Kanthasamy AG
    J Biol Chem; 2013 Jul; 288(30):21955-71. PubMed ID: 23754278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of transcription factor SP1 produces neuroprotective effects through decreasing MAO B activity in MPTP/MPP
    Yao L; Dai X; Sun Y; Wang Y; Yang Q; Chen X; Liu Y; Zhang L; Xie W; Liu J
    J Neurosci Res; 2018 Oct; 96(10):1663-1676. PubMed ID: 30004136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson's disease.
    Kawamata J; Suzuki S; Shimohama S
    Curr Drug Targets; 2012 May; 13(5):623-30. PubMed ID: 22300030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Effects of Antidepressants via Upregulation of Neurotrophic Factors in the MPTP Model of Parkinson's Disease.
    Shadfar S; Kim YG; Katila N; Neupane S; Ojha U; Bhurtel S; Srivastav S; Jeong GS; Park PH; Hong JT; Choi DY
    Mol Neurobiol; 2018 Jan; 55(1):554-566. PubMed ID: 27975170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orexin B protects dopaminergic neurons from 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity associated with reduced extracellular signal-regulated kinase phosphorylation.
    Ma X; Cao F; Cui J; Li X; Yin Z; Wu Y; Wang Q
    Mol Biol Rep; 2024 May; 51(1):669. PubMed ID: 38787465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.